Vortex Energy【VRTX】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.045

買値

0.045

売値

0.05

出来高

54,879

0.045 日の範囲 0.05

0.045 52 週間の範囲 0.85

前日終値

0.045

始値

0.045

時刻

5000

0.045

最終取引時間

平均取引量 (3 か月)

126,942

財務取引量

VWAP

Vertex Pharmaceuticals Announces the Date of its Third Quarter 2006 Financial Results Conference Call and Webcast

CAMBRIDGE, Mass., Oct. 9 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will announce its third quarter 2006 financial results on Thursday, October 26, 2006...

Vertex Pharmaceuticals Announces Completion of Common Stock Offering

CAMBRIDGE, Mass., Sept. 20 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the completion of its public offering of 9,100,000 shares of common...

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

CAMBRIDGE, Mass., Sept. 18 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) will webcast corporate presentations at Merrill Lynch's Global Pharmaceutical, Biotech...

Vertex Pharmaceuticals Announces Pricing of Common Stock Offering

CAMBRIDGE, Mass., Sept. 14 /PRNewswire-FirstCall/ -- Vertex Pharmaceuticals Incorporated (Nasdaq GS: VRTX) today announced the pricing of its public offering of 9,100,000 shares of its common...

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680

Vertex and Merck Initiate Clinical Study in Hematologic Cancers with Aurora Kinase Inhibitor VX-680 WHITEHOUSE STATION, N.J. and CAMBRIDGE, Mass., June 17 /PRNewswire/ -- Merck & Co., Inc...

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor

Vertex Pharmaceuticals Reports Positive Results from First-in-Human Study for VX-950, an Investigational Oral Protease Inhibitor for the Treatment of Hepatitis C -- Encouraging Results Support...

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC

Studies of Sustained Efficacy/Tolerability of LEXIVA After 96 Weeks of Treatment Presented at IAC BANGKOK, Thailand, July 13 /PRNewswire-FirstCall/ -- The protease inhibitor (PI) LEXIVA(R...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.01	-18.1818181818	0.055	0.055	0.045	118732	0.04543375	CS
4	-0.015	-25	0.06	0.06	0.045	119029	0.04797274	CS
12	-0.07	-60.8695652174	0.115	0.115	0.045	126942	0.06631001	CS
26	-0.18	-80	0.225	0.235	0.045	97342	0.10038616	CS
52	-0.355	-88.75	0.4	0.85	0.045	159148	0.35450121	CS
156	-0.055	-55	0.1	2.32	0.045	197020	0.90154692	CS
260	-0.055	-55	0.1	2.32	0.045	197020	0.90154692	CS

VRTX - Frequently Asked Questions (FAQ)

What is the current Vortex Energy share price?

The current share price of Vortex Energy is $ 0.045

What is the 1 year trading range for Vortex Energy share price?

Vortex Energy has traded in the range of $ 0.045 to $ 0.85 during the past year

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
XBLK.XeXeBlock Technology Corporation	$ 0.05 (150.00%)	312.24k
CCRGreen River Gold Corp	$ 0.01 (100.00%)	2.1k
KVMKingsview Minerals Ltd	$ 0.01 (100.00%)	1,000
MYTCMyndTec Inc	$ 0.20 (100.00%)	1,000
AJNAJN Resources Inc	$ 0.10 (81.82%)	12k
XCXAMP Alternative Medical Products Inc	$ 0.01 (-89.47%)	2k
MJRXGlobal Health Clinics Ltd	$ 0.01 (-75.00%)	7.5k
NIRVNirvana Life Sciences Inc	$ 0.025 (-66.67%)	3k
CLSHCLS Holdings USA Inc	$ 0.02 (-60.00%)	60.26k
PMAXPowermax Minerals Inc	$ 0.70 (-51.72%)	5.5k
TRIPRed Light Holland Corp	$ 0.04 (0.00%)	3.53M
QIMCQuebec Innovative Materials Corp	$ 0.09 (5.88%)	2.17M
SOLSOL Global Investments Corp	$ 0.36 (0.00%)	2.05M
HODLSol Strategies Inc	$ 2.64 (23.36%)	1.73M
AFXArctic Fox Lithium Corp	$ 0.005 (-50.00%)	1.45M